Is There a Relationship Between Frequency of Port-Care Maintenance and Related Complications in Patients With Cancer?
暂无分享,去创建一个
T. Lang | G. Richardson | Joseph G O'Sullivan | Sarah Jaboury | Alexander West | Kirsten Seletto | Lucy Wilson | Elizabeth Gleisner
[1] A. Bodenham,et al. Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial , 2021, The Lancet.
[2] K. Chìn,et al. Clinical utility of polyethylene glycol conjugated granulocyte colony-stimulating factor (PEG-G-CSF) for preventing severe neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI plus bevacizumab: a single-center retrospective study , 2020, BMC Cancer.
[3] W. Schima,et al. Complications of central venous port systems: a pictorial review , 2019, Insights into Imaging.
[4] Hossam Abdel Rahman,et al. Efficacy of primary prophylactic GCSF in patients receiving docetaxel based chemotherapy for breast cancer. , 2018 .
[5] D. Lebeaux,et al. Removal of totally implanted venous access ports for suspected infection in the intensive care unit: a multicenter observational study , 2018, Annals of Intensive Care.
[6] C. Johnstone,et al. Bleeding in cancer patients and its treatment: a review. , 2018, Annals of palliative medicine.
[7] S. Rai,et al. Phase II Trial on Extending the Maintenance Flushing Interval of Implanted Ports. , 2017, Journal of oncology practice.
[8] J. Cata,et al. Blood transfusion practices in cancer surgery , 2014, Indian journal of anaesthesia.
[9] E. Moraes,et al. Safety of every 90 days portacath heparin maintenance flush in patients with cancer. , 2014 .
[10] N. Zengi̇n,et al. Effect of port-care frequency on venous port catheter-related complications in cancer patients , 2014, International Journal of Clinical Oncology.
[11] M. Gorman,et al. Central venous catheter care for the patient with cancer: American Society of Clinical Oncology clinical practice guideline. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] L. Rasero,et al. The late complications of totally implantable central venous access ports: the results from an Italian multicenter prospective observation study. , 2011, European journal of oncology nursing : the official journal of European Oncology Nursing Society.
[13] Sanjay Saint,et al. Guidelines for the prevention of intravascular catheter-related infections. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] C. Drenzek,et al. Catheter-Related Polymicrobial Bloodstream Infections among Pediatric Bone Marrow Transplant Outpatients—Atlanta, Georgia, 2007 , 2010, Infection Control & Hospital Epidemiology.
[15] T. Ignatov,et al. Interval between Port Catheter Flushing Can Be Extended to Four Months , 2010, Gynecologic and Obstetric Investigation.
[16] S. Loibl,et al. Management of venous port systems in oncology: a review of current evidence. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.
[17] M. Krzakowski,et al. Totally implantable central venous access ports , 2006 .
[18] A. Fields,et al. How Often Should a Port-A-Cath be Flushed? , 2005, Cancer investigation.
[19] W. Haire,et al. Are clinical signs accurate indicators of the cause of central venous catheter occlusion? , 1995, JPEN. Journal of parenteral and enteral nutrition.